Life-Saving Information Available at NET Cancer Patient Conference

Written by Carcinoid Cancer awareness network  |  27. July 2011

(North Bellmore, NY) -The president of a non-profit group that promotes awareness of neuroendocrine cancer has announced the Carcinoid Cancer Awareness Network's 2011 Long Island Neuroendocrine Cancer Patient Conference, being held at the Holiday Inn, Carle Place on August 20th. According to Bob Wahmann of CCAN, "the faculty and the topics being covered at this event are absolutely astounding. CCAN wants these conferences to be affordable so we only charge a small commitment fee to attendees. I wish we could promote this event more extensively. If you are a medical care provider or a patient with a neuroendocrine cancer, you will hear things at this conference that can really change lives." The full day event includes presentations by 5 neuroendocrine cancer experts, an expert question & answer panel, lunch, snacks and networking. Here is a perfect opportunity to learn from some of the foremost experts in the world: Dr. Hal Gerstein, Dr. Steven Libutti, Dr. Patrick C. Molloy, Dr. Thomas O'Dorisio, nutritionist Leigh Ann Burns and Dr. Ebrahim Delpassand- all members of the North American Neuroendocrine Tumor Society (NANETS.) Topics will cover: 'Prioritizing Treatment Options for NET Cancer Patients' 'What Is The Role of Surgery In NET Cancer?' 'Neuroendocrine Tumors: Recognition, Potential New Therapies and a Look at the Future' 'Choosing Options of Care and the Value of Tumor Markers in the Process' 'What's New in PRRT Treatments for Neuroendocrine Tumors?' 'Proper Nutrition for NET Cancer Patients' Who Should Attend the Long Island Conference? Doctors, nurses, physician's assistants, students, techs, patients, caregivers- anyone who might be in a position to suspect, diagnose, treat and help carcinoid / NET cancer patients. Medical professionals will also have the opportunity to join the North American NeuroEndocrine Tumor Society (NANETS.) The purpose of this professional organization is to improve NET disease management through increased research and educational opportunities. Think NET cancer is rare? There are over 120,000 patients in the US that don't agree, and 12,000 new ones diagnosed every year. Patients need to be involved so that they are aware of the treatment options available to them. Nationally known Carcinoid/NET expert Dr. Eugene Woltering explains that "educating neuroendocrine cancer patients is one of the best methods of getting current information into the hands of the medical community." This concept works! Recently a new patient was diagnosed by a dermatologist because of information given to her by a carcinoid cancer survivor. Maryann Wahmann, VP of CCAN and herself a carcinoid cancer survivor tells us that "These events definitely save lives! My husband and I went to our first patient conference in 2003 and were absolutely shocked by the information we got there that we didn't get from our local doctors. Going there saved my life. Because NET cancer has no celebrity spokesperson and little publicity, our researchers get modest funding. Many carcinoid cancer patients go untreated for years or are told they have other problems." Call CCAN's office at 516-781-7814 or email carcinoidaware@aol.com for more information.

Copyright © 1996-2021 LongIsland.com & Long Island Media, Inc. All rights reserved.